| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 125.65B | 122.34B | 122.43B | 120.74B | 134.04B |
| Gross Profit | 100.22B | 52.53B | 53.53B | 69.89B | 73.63B |
| EBITDA | 54.70B | 44.02B | 45.32B | 21.07B | 53.72B |
| Net Income | 21.89B | 10.95B | 14.40B | -8.52B | 20.08B |
Balance Sheet | |||||
| Total Assets | 420.20B | 394.80B | 407.06B | 402.85B | 551.62B |
| Cash, Cash Equivalents and Short-Term Investments | 18.23B | 3.30B | 6.72B | 3.70B | 19.22B |
| Total Debt | 173.99B | 140.92B | 154.90B | 154.68B | 195.83B |
| Total Liabilities | 291.71B | 274.57B | 287.64B | 296.40B | 367.77B |
| Stockholders Equity | 110.53B | 104.37B | 103.30B | 97.50B | 166.33B |
Cash Flow | |||||
| Free Cash Flow | 19.44B | 18.51B | 20.46B | 12.40B | 25.43B |
| Operating Cash Flow | 40.28B | 38.77B | 38.31B | 32.02B | 41.96B |
| Investing Cash Flow | -18.78B | -17.49B | -19.66B | -25.80B | -32.09B |
| Financing Cash Flow | -6.39B | -24.71B | -15.61B | -23.74B | 1.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $99.52B | 5.14 | 20.98% | 4.42% | 0.20% | 61.54% | |
74 Outperform | $218.84B | 20.84 | 18.18% | 1.75% | 7.30% | 17.67% | |
72 Outperform | $207.30B | 10.02 | 16.62% | 6.60% | 2.42% | 102.17% | |
67 Neutral | $198.26B | 8.14 | 20.35% | 4.56% | 1.98% | 150.68% | |
62 Neutral | $77.41B | 14.48 | 17.05% | 2.69% | 1.14% | 83.48% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | $31.27B | 5.66 | 31.24% | ― | 0.42% | 13.46% |